Temple Lung Center: Advancing Research in ILD

Interstitial lung diseases (ILD) significantly impact patient morbidity and mortality. As an ILD Center of Excellence, the Temple Lung Center has established comprehensive programs for the evaluation and management of patients with a wide range of ILDs. This includes extensive clinical research and lung transplantation expertise.

April 28, 2025
2 min

Temple Health

At a Glance

Category	Detail
Condition	Interstitial Lung Diseases (ILD)
Key Mechanisms	Impact on patient morbidity and mortality; involvement of connective tissue diseases.
Target Population	Patients with various forms of ILD, including idiopathic pulmonary fibrosis and scleroderma-related ILD.
Care Setting	ILD Center of Excellence with comprehensive evaluation and management programs.

Key Highlights

Comprehensive programs for evaluation and management of ILDs.
Expertise in lung transplantation for patients with esophageal dysfunction.
Innovative clinical trials focusing on targeted therapies.
Experience in transplants for various ILDs related to connective tissue diseases.
Active enrollment in clinical trials for patients with progressive pulmonary fibrosis.

Guideline-Based Recommendations

Diagnosis

Comprehensive evaluation of ILD patients at specialized centers.

Management

Utilization of targeted therapies via inhaled, oral, or subcutaneous routes.

Monitoring & Follow-up

Regular assessment of lung function and disease progression.

Risks

Morbidity and mortality associated with untreated ILDs.

Patient & Prescribing Data

Patients with idiopathic pulmonary fibrosis, scleroderma-related ILD, and other connective tissue disease-related ILDs.

Participation in clinical trials for innovative therapies is encouraged.

Clinical Best Practices

Engage patients in clinical trials for cutting-edge treatment options.
Utilize a triage map to identify appropriate studies for patients.
Provide comprehensive care through specialized ILD centers.

References

Temple Lung Center Clinical Trials

Temple Lung Center: Advancing Research in ILD

Clinical Scorecard: Temple Lung Center: Advancing Research in ILD

At a Glance

Key Highlights

Guideline-Based Recommendations

Diagnosis

Management

Monitoring & Follow-up

Risks

Patient & Prescribing Data

Clinical Best Practices

References

Original Source(s)

Temple Lung Center: Advancing Research in ILD

Related Content

Trauma CT and Unexpected Findings

Cytomegalovirus DNA Presence in Southern Chinese Patients with Anti-Melanoma Differentiation-Associated Gene 5 Positive Dermatomyositis

Advancing Pulmonary Vascular Disease Care Through Research